Detection of oncogenic and clinically actionable mutations in cancer genomes critically depends on variant calling tools. - Carlos A. Garcia-Prieto; Francisco Martínez-Jiménez; Alfonso Valencia; Eduard Porta-Pardo (Bioinform., 2022)